SCHEMBL38655152

SCHEMBL38655152

C=CCC1CC(=O)c2ccc(Br)cc2O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.43
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
AR P10275 1/20 0.37
MAOB P27338 13/20 0.36
CYP19A1 P11511 2/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
YES1 P07947 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
ESR2 Q92731 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38657092 0.87 PBRM1 (0.44) PBRM1HTR2AHTR2CARMAOB
SCHEMBL17141505 0.81 PBRM1 (0.50) PBRM1ARMAOBCYP19A1TUBB4A
SCHEMBL38655053 0.80 MAOB (0.36) MAOBCYP19A1TUBB4ATUBBYES1
SCHEMBL6920340 0.80 MAOB (0.51) ARMAOBCYP19A1
SCHEMBL9819102 0.73 PBRM1 (0.77) PBRM1ARMAOBCYP19A1TUBB4A
SCHEMBL1933329 0.70 MAOB (0.69) ARMAOBCYP19A1TUBB4ATUBB
SCHEMBL15537413 0.70 PBRM1 (0.66) PBRM1ARMAOBCYP19A1MAOA
SCHEMBL6711965 0.70 MAOB (0.69) ARMAOBCYP19A1TUBB4ATUBB
SCHEMBL19433632 0.70 SIRT2 (0.40) ARMAOBCYP19A1TUBB4ATUBB
SCHEMBL6828122 0.70 PBRM1 (0.61) PBRM1ARMAOBCYP19A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026103738-A1 BRIDGED CYCLIC 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-D] PYRROLO [3, 2-B] PYRIDINE-2-CARBOXAMIDE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH BEONE PHARMACEUTICAL (SUZHOU) CO., LTD. (CN) 2026-05-21 WO disclosed
US-20260132149-A1 Bridged Cyclic 5-Amino-6,8-Dihydro-1H-Furo[3,4-D]Pyrrolo[3,2-B]Pyridine-2-Carboxamide Compounds, Compositions Thereof, and Methods of Treatment Therewith BEONE MEDICINES I GMBH (CH) 2026-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132149-A1 Bridged Cyclic 5-Amino-6,8-Dihydro-1H-Furo[3,4-D]Pyrrolo[3,2-B]Pyridine-2-Carboxamide Compounds, Compositions Thereof, and Methods of Treatment Therewith MECP2, PRMT5, DNMT1 PBRM1 64/4885HTR2A 2951/4885HTR2C 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.